Navigation Links
NIH doubles support for vital HIV/AIDS research center
Date:11/1/2007

The National Institutes of Health will award $15 million over the next five years to the Center for AIDS Research of the University of California, San Francisco and the Gladstone Institute for Virology and Immunology to continue its pioneering translational researcha doubling of its previous five-year award.

The UCSF-GIVI Center for AIDS Research is absolutely crucial to maintaining and extending the leadership role of San Francisco in responding to the HIV epidemic. It brings together a true community of HIV investigators who represent the many disciplines and campus sites involved in this effort, said Paul Volberding, MD, the centers co-director and professor and vice-chair, UCSF Department of Medicine and Chief of the Medical Service at the San Francisco Veterans Affairs Medical Center.

Co-directed by Warner Greene, MD, PhD, director of the UCSF affiliated GIVI, the Center for AIDS Research provides strategic, educational and scientific services to HIV/AIDS researchers. Its research goal is to expand the intersections of basic, clinical and behavioral/epidemiological HIV research. It provides infrastructure support to over $80 million of funded HIV/AIDS research at UCSF and affiliated institutions.

CFAR is particularly vital in encouraging the collaborations across conventional scientific disciplines that can direct the amazing expertise of UCSF scientists to address the newest challenges of HIV disease. As we address scientific and clinical challenges here in San Francisco as well as in the world-wide epidemic, CFAR will provide the essential infrastructure to facilitate the most important and innovative science we all depend on, said Greene.

The NIH CFAR program, first funded in 1988, currently supports 19 centers based at leading HIV/AIDS research institutions. UCSF was one of the first institutions to be funded under this program. In 2003, the program was modified to provide greater funding to larger institutions.

The growth plans of CFAR include expanding the number of pilot awards available including funding specific pilots in basic science and for mentoring of foreign scientists. In addition, direct support will be increased for the centers highly successful mentoring program and support for international collaborations, specifically in Eastern Africa.

CFAR provides essential infrastructure for HIV/AIDS research through its clinical and population sciences, immunology (including flow core), virology, specimen bank, and pharmacology cores. These cores provide access to cohorts, assays and services.

CFAR has succeeded in stimulating several advances in HIV/AIDS research, including:

  • Delineating the biology of the APOBEC3G protein in anti-viral immunity

  • Boosting thymic function

  • Changes in viral fitness as a result of antiretroviral drug resistance

  • Understanding the immunopathogenicity of protease inhibitor-resistant HIV

  • In Vivo Assessment of Thymic Function and T-Cell Activation in Patients with Drug-resistant and wild-type HIV

  • Atherosclerosis in HIV Disease

  • Adherence and drug resistance in the United States and Uganda

  • Dissecting the molecular basis of HIV latency

  • Inpatient HIV testing and counseling in Uganda

  • Studies of the interactions between HIV and malaria.


'/>"/>

Contact: Jeff Sheehy
jsheehy@ari.ucsf.edu
415-597-8165
University of California - San Francisco
Source:Eurekalert

Related medicine news :

1. Breast cancer risk doubles by high sex hormone levels
2. Down syndrome life anticipation doubles
3. Depression doubles mortality risk after CABG
4. China Doubles Its Investment In AIDS/HIV Treatment.
5. Colon Cancer Death Rate Doubles As Patients Stop Chemotherapy
6. High Carb Diet Doubles Fat Loss
7. Sleep Apnea Doubles Stroke Risk In Elderly
8. Brains pleasure chemical doubles up for pain as well
9. Sight loss risk doubles in overweight people
10. Stroke Risk Nearly Doubles for Siblings of People Who Have Had a Stroke
11. Snacking While Driving Doubles Accident Rates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... Z-Medica, ... have teamed up with The American College of Surgeons (ACS) to provide basic ... Trauma, the “Bleeding Control Basic” course is a pilot program that fulfills the ...
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... (PRWEB) , ... December 03, ... ... German Newall wins "Best Surgical Body Shaping" at the 2016 Anti-Aging ... in Paris, France. , The Aesthetic & Anti-Aging Medicine European Congress ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... ... Halfway through its partnership with First 5 LA, Western University of Health Sciences’ ... 5 years old and younger and treatment services to more than 9,100 of these ... to Western University of Health Sciences, UCLA and USC, beginning March 1, 2013, to ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... --  Pairnomix, LLC, a genetic research company and member ... White House, today announced that findings from its first case ... therapies for a patient with epileptic encephalopathy caused by a ... the 70 th Annual Meeting of the American ... December 2-6, 2016.  Pairnomix, unique process involves creating ...
(Date:12/2/2016)... 2, 2016 Research and Markets has announced ... to their offering. ... , R&D Drug Pipeline Database: ... R&D Drug Pipeline Database provides 24/7 online access to information about ... market and on investigational drug candidates in research & development. ...
(Date:12/2/2016)... the ECG Cables And ECG Leadwires Market owing to the ... On the other hand, the Asia-Pacific ... during the forecast period. The market players namely, ... ( Ireland ), Koninklijke Philips N.V. ( ... China ), held major share of the ECG ...
Breaking Medicine Technology: